{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:40:30Z","timestamp":1783431630334,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506000"],"award-info":[{"award-number":["2023YFC2506000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05675-9","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T01:12:03Z","timestamp":1745629923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolism-related hepatokines change in biliary atresia: ANGPTL6 as a potential biomarker"],"prefix":"10.1186","volume":"25","author":[{"given":"Daiqiong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfa","family":"Tou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"6","key":"5675_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","volume":"12","author":"A Asai","year":"2015","unstructured":"Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary Atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol. 2015;12(6):342\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5675_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1440-1746.2007.05114.x","volume":"23","author":"MM Tiao","year":"2008","unstructured":"Tiao MM, Tsai SS, Kuo HW, Chen CL, Yang CY. Epidemiological features of biliary Atresia in Taiwan, a National study 1996\u20132003. J Gastroenterol Hepatol. 2008;23(1):62\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9418","key":"5675_CR3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/S0140-6736(04)16045-5","volume":"363","author":"M Davenport","year":"2004","unstructured":"Davenport M, De Ville de Goyet J, Stringer MD, Mieli-Vergani G, Kelly DA, McClean P, Spitz L. Seamless management of biliary Atresia in England and Wales (1999\u20132002). Lancet. 2004;363(9418):1354\u20137.","journal-title":"Lancet"},{"key":"5675_CR4","doi-asserted-by":"publisher","first-page":"103689","DOI":"10.1016\/j.ebiom.2021.103689","volume":"74","author":"U Lendahl","year":"2021","unstructured":"Lendahl U, Lui VCH, Chung PHY, Tam PKH. Biliary Atresia - emerging diagnostic and therapy opportunities. EBioMedicine. 2021;74:103689.","journal-title":"EBioMedicine"},{"key":"5675_CR5","first-page":"113","volume":"6","author":"BH Landing","year":"1974","unstructured":"Landing BH. Considerations of the pathogenesis of neonatal hepatitis, biliary Atresia and choledochal cyst\u2013the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg. 1974;6:113\u201339.","journal-title":"Prog Pediatr Surg"},{"key":"5675_CR6","doi-asserted-by":"publisher","first-page":"105138","DOI":"10.1016\/j.ebiom.2024.105138","volume":"103","author":"MH Xiao","year":"2024","unstructured":"Xiao MH, Wu S, Liang P, Ma D, Zhang J, Chen H, Zhong Z, Liu J, Jiang H, Feng X, et al. Mucosal-associated invariant T cells promote ductular reaction through Amphiregulin in biliary Atresia. EBioMedicine. 2024;103:105138.","journal-title":"EBioMedicine"},{"issue":"286","key":"5675_CR7","doi-asserted-by":"publisher","first-page":"286ra267","DOI":"10.1126\/scitranslmed.aaa1652","volume":"7","author":"K Lorent","year":"2015","unstructured":"Lorent K, Gong W, Koo KA, Waisbourd-Zinman O, Karjoo S, Zhao X, Sealy I, Kettleborough RN, Stemple DL, Windsor PA, et al. Identification of a plant isoflavonoid that causes biliary Atresia. Sci Transl Med. 2015;7(286):286ra267.","journal-title":"Sci Transl Med"},{"key":"5675_CR8","doi-asserted-by":"crossref","unstructured":"Hai-Bing Y, Sivasankaran MS, Ottakandathil BR, Zhong-Luan W, Man-Ting S, Ho-Yu CP, Kak-Yuen WK, Kwong-Hang TP, Chi-Hang LV. Environmental toxin Biliatresone-Induced biliary Atresia-like abnormal cilia and bile duct cell development of human liver organoids. Toxins (Basel) 2024, 16(3).","DOI":"10.3390\/toxins16030144"},{"issue":"5","key":"5675_CR9","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2013.01.022","volume":"144","author":"S Cui","year":"2013","unstructured":"Cui S, Leyva-Vega M, Tsai EA, EauClaire SF, Glessner JT, Hakonarson H, Devoto M, Haber BA, Spinner NB, Matthews RP. Evidence from human and zebrafish that GPC1 is a biliary Atresia susceptibility gene. Gastroenterology. 2013;144(5):1107\u2013e11151103.","journal-title":"Gastroenterology"},{"key":"5675_CR10","doi-asserted-by":"crossref","unstructured":"Lim YZ, Zhu M, Wang Y, Sharma T, Kelley S, Oertling E, Zhu H, Corbitt N. Pkd1l1-deficiency drives biliary Atresia through ciliary dysfunction in biliary epithelial cells. J Hepatol 2024.","DOI":"10.1016\/j.jhep.2024.02.031"},{"issue":"6","key":"5675_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJMc1601230","volume":"375","author":"S Harpavat","year":"2016","unstructured":"Harpavat S, Garcia-Prats JA, Shneider BL. Newborn bilirubin screening for biliary Atresia. N Engl J Med. 2016;375(6):605\u20136.","journal-title":"N Engl J Med"},{"key":"5675_CR12","first-page":"733","volume":"13","author":"MS Kasai","year":"1959","unstructured":"Kasai MS. A new operation for non-correctable biliary Atresia: hepatic portoenterostomy. Shujutsu. 1959;13:733\u20139.","journal-title":"Shujutsu"},{"issue":"4","key":"5675_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/MPG.0b013e318282a913","volume":"56","author":"C Jimenez-Rivera","year":"2013","unstructured":"Jimenez-Rivera C, Jolin-Dahel KS, Fortinsky KJ, Gozdyra P, Benchimol EI. International incidence and outcomes of biliary Atresia. J Pediatr Gastroenterol Nutr. 2013;56(4):344\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5675_CR14","doi-asserted-by":"publisher","first-page":"108439","DOI":"10.1016\/j.compbiomed.2024.108439","volume":"174","author":"X Chen","year":"2024","unstructured":"Chen X, Zhao D, Ji H, Chen Y, Li Y, Zuo Z. Predictive modeling for early detection of biliary Atresia in infants with cholestasis: insights from a machine learning study. Comput Biol Med. 2024;174:108439.","journal-title":"Comput Biol Med"},{"issue":"3","key":"5675_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOL.0000000000000599","volume":"30","author":"D Struik","year":"2019","unstructured":"Struik D, Dommerholt MB, Jonker JW. Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application. Curr Opin Lipidol. 2019;30(3):235\u201343.","journal-title":"Curr Opin Lipidol"},{"key":"5675_CR16","first-page":"193","volume":"6","author":"VJ Nies","year":"2015","unstructured":"Nies VJ, Sancar G, Liu W, van Zutphen T, Struik D, Yu RT, Atkins AR, Evans RM, Jonker JW, Downes MR. Fibroblast growth factor signaling in metabolic regulation. Front Endocrinol (Lausanne). 2015;6:193.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"5675_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2012.258","volume":"9","author":"N Stefan","year":"2013","unstructured":"Stefan N, Haring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 2013;9(3):144\u201352.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"5675_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00125-015-3634-4","volume":"58","author":"A Iroz","year":"2015","unstructured":"Iroz A, Couty JP, Postic C. Hepatokines: unlocking the multi-organ network in metabolic diseases. Diabetologia. 2015;58(8):1699\u2013703.","journal-title":"Diabetologia"},{"key":"5675_CR19","doi-asserted-by":"crossref","unstructured":"Carbone C, Piro G, Merz V, Simionato F, Santoro R, Zecchetto C, Tortora G, Melisi D. Angiopoietin-Like proteins in angiogenesis, inflammation and cancer. Int J Mol Sci 2018, 19(2).","DOI":"10.3390\/ijms19020431"},{"issue":"3","key":"5675_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4(3):215\u201366.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"5","key":"5675_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0960-9822(95)00102-3","volume":"5","author":"AO Wilkie","year":"1995","unstructured":"Wilkie AO, Morriss-Kay GM, Jones EY, Heath JK. Functions of fibroblast growth factors and their receptors. Curr Biol. 1995;5(5):500\u20137.","journal-title":"Curr Biol"},{"issue":"9","key":"5675_CR22","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007;27(9):3417\u201328.","journal-title":"Mol Cell Biol"},{"issue":"37","key":"5675_CR23","doi-asserted-by":"publisher","first-page":"26687","DOI":"10.1074\/jbc.M704165200","volume":"282","author":"H Kurosu","year":"2007","unstructured":"Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro OM. Tissue-specific expression of betaklotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem. 2007;282(37):26687\u201395.","journal-title":"J Biol Chem"},{"issue":"4","key":"5675_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/SLA.0b013e3182300950","volume":"254","author":"R Superina","year":"2011","unstructured":"Superina R, Magee JC, Brandt ML, Healey PJ, Tiao G, Ryckman F, Karrer FM, Iyer K, Fecteau A, West K, et al. The anatomic pattern of biliary Atresia identified at time of Kasai Hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg. 2011;254(4):577\u201385.","journal-title":"Ann Surg"},{"key":"5675_CR25","doi-asserted-by":"crossref","unstructured":"Calinescu AM, Madadi-Sanjani O, Mack C, Schreiber RA, Superina R, Kelly D, Petersen C, Wildhaber BE. Cholangitis definition and treatment after Kasai Hepatoportoenterostomy for biliary Atresia: A Delphi process and international expert panel. J Clin Med 2022, 11(3).","DOI":"10.3390\/jcm11030494"},{"issue":"4","key":"5675_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MPG.0b013e31825bb01a","volume":"55","author":"Z Song","year":"2012","unstructured":"Song Z, Dong R, Fan Y, Zheng S. Identification of serum protein biomarkers in biliary Atresia by mass spectrometry and enzyme-linked immunosorbent assay. J Pediatr Gastroenterol Nutr. 2012;55(4):370\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5675_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cyto.2016.03.003","volume":"83","author":"D Li","year":"2016","unstructured":"Li D, Lu T, Shen C, Liu Y, Zhang J, Shan Y, Luo Y, Xi Z, Qiu B, Chen Q, et al. Expression of fibroblast growth factor 21 in patients with biliary Atresia. Cytokine. 2016;83:13\u20138.","journal-title":"Cytokine"},{"issue":"5","key":"5675_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/joim.13028","volume":"287","author":"H Johansson","year":"2020","unstructured":"Johansson H, Svensson JF, Almstrom M, Van Hul N, Rudling M, Angelin B, Nowak G, Fischler B, Ellis E. Regulation of bile acid metabolism in biliary Atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome. J Intern Med. 2020;287(5):534\u201345.","journal-title":"J Intern Med"},{"issue":"4","key":"5675_CR29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/HEP.0000000000000048","volume":"77","author":"I Nyholm","year":"2023","unstructured":"Nyholm I, Hukkinen M, Pihlajoki M, Davidson JR, Tyraskis A, Lohi J, Heikkila P, Hanninen S, Andersson N, Eloranta K, et al. Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary Atresia. Hepatology. 2023;77(4):1263\u201373.","journal-title":"Hepatology"},{"key":"5675_CR30","doi-asserted-by":"crossref","unstructured":"Lertudomphonwanit C, Mourya R, Fei L, Zhang Y, Gutta S, Yang L, Bove KE, Shivakumar P, Bezerra JA. Large-scale proteomics identifies MMP-7 as a Sentinel of epithelial injury and of biliary Atresia. Sci Transl Med 2017, 9(417).","DOI":"10.1126\/scitranslmed.aan8462"},{"issue":"6","key":"5675_CR31","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/hep.30234","volume":"68","author":"L Yang","year":"2018","unstructured":"Yang L, Zhou Y, Xu PP, Mourya R, Lei HY, Cao GQ, Xiong XL, Xu H, Duan XF, Wang N, et al. Diagnostic accuracy of serum matrix Metalloproteinase-7 for biliary Atresia. Hepatology. 2018;68(6):2069\u201377.","journal-title":"Hepatology"},{"key":"5675_CR32","doi-asserted-by":"crossref","unstructured":"Pandurangi S, Mourya R, Nalluri S, Fei L, Dong S, Harpavat S, Guthery SL, Molleston JP, Rosenthal P, Sokol RJ et al. Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort. Hepatology 2024.","DOI":"10.1097\/HEP.0000000000000827"},{"issue":"4","key":"5675_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nm1214","volume":"11","author":"Y Oike","year":"2005","unstructured":"Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, Urano T, Kimura Y, Kubota Y, Maekawa H, et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med. 2005;11(4):400\u20138.","journal-title":"Nat Med"},{"issue":"4","key":"5675_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.metabol.2010.05.013","volume":"60","author":"J Namkung","year":"2011","unstructured":"Namkung J, Koh SB, Kong ID, Choi JW, Yeh BI. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism. 2011;60(4):564\u20138.","journal-title":"Metabolism"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05675-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05675-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T14:02:15Z","timestamp":1745676135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05675-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5675"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05675-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of The Children \u0301s Hospital, Zhejiang University School of Medicine (2019-IRB-018; March 11,2019). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}